Skip to main content
Corporate
CGS Administrators, LLC

IVR: 866.238.9650 Customer Service and myCGS: 866.270.4909

April 16, 2020

External Infusion Pumps Final LCD (L33794) and Response to Comments (RTC) Article Published

Joint DME MAC Publication

Today, the DME MACs published the External Infusion Pumps Final LCD (L33794External Website) and LCD-related Policy Article (PA) (A52507External Website). The policy extends coverage of Xembify® as reasonable and necessary for the treatment of beneficiaries with a diagnosis of primary immune deficiency (PID) disease, when coverage criteria are met. The posting of the final LCD marks the beginning of the 45-day notice period. The final LCD will be effective May 31, 2020.

The DME MACs have also posted a response to all written comments received during the comment period, in a Response to Comments (RTC) Article (A58071External Website).

Please refer to each DME MAC website for additional information about policy development and copies of the final LCD.

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved